Promising trials of malaria vaccine lead to calls for Phase 3 development
Tuesday, December 9, 2008 - 01:23
in Health & Medicine
Experts are recommending that a malaria vaccine progress to Phase 3 trials following the successful trial of the RTS, S/AS01E malaria vaccine among 5-17 month old children in Korogwe, Tanzania and coastal Kenya, which is reported today in the New England Journal of Medicine (NEJM).
Read the whole article on Biology News Net
More from Biology News Net
Related
- Promising trials of malaria vaccine lead to calls for Phase 3 developmentMon, 8 Dec 2008, 12:32:14 EST
- IAVI statement in response to NIAID decision not to move forward with PAVE 100 HIV Vaccine TrialThu, 17 Jul 2008, 12:14:46 EDT
- India continues to progress in AIDS vaccine development effortsMon, 18 Aug 2008, 0:22:02 EDT
- Novel tuberculosis vaccine in Germany in clinical phaseThu, 11 Sep 2008, 11:16:59 EDT
- Early results: In children, 2009 H1N1 influenza vaccine works like seasonal flu vaccineMon, 21 Sep 2009, 11:24:18 EDT